Efficacy and safety of ledipasvir/sofosubuvir/ribavirin combination therapy for failures to daculatasvir/asunaprevir combination therapy.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 22 Nov 2016 Status changed from not yet recruiting to recruiting.
- 09 Jun 2016 New trial record